Literature DB >> 7020889

Intravenous glucose tolerance test during anaesthesia in dogs: insulin response and glucose clearance.

H Ishihara, F T Kallus, A H Giesecke.   

Abstract

To evaluate the insulin response and the rates of disappearance of glucose from plasma during high spinal analgesia and various types of general anaesthesia, a series of intravenous glucose tolerance tests was performed in six dogs. Plasma glucose and insulin levels were measured during the intravenous glucose tolerance tests. Insulinogenic indices were calculated. The values obtained during anaesthesia were compared to those obtained during an unanaesthetized state. The insulinogenic index was increased significantly during high spinal analgesia and thiopentone infusion. Halothane and enflurane anaesthesia decreased the insulinogenic index significantly while Innovar-nitrous oxide also decreased it, but not significantly. These findings suggest that insulin secretion in response to hyperglycaemia is stimulated by spinal analgesia and thiopentone anaesthesia, depressed by halothane and enflurane anaesthesia and unchanged during neuroleptanesthesia. A diuresis was observed in the thiopentone anaesthetic and spinal analgesic groups as compared to the other general anaesthetic groups. Urinary losses of insulin and glucose paralleled urinary output; yet the greatest mean urinary loss of glucose did not exceed 4.5 per cent of the load of glucose administered. Accordingly, 95 per cent of the administered glucose remained within the body, presumably available for utilization.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7020889     DOI: 10.1007/bf03007807

Source DB:  PubMed          Journal:  Can Anaesth Soc J        ISSN: 0008-2856


  22 in total

1.  An o-toluidine method for body-fluid glucose determination.

Authors:  K M DUBOWSKI
Journal:  Clin Chem       Date:  1962 May-Jun       Impact factor: 8.327

2.  New techniques for spinal anesthesia in the dog.

Authors:  C L Redderson; D Uy; A H Anton
Journal:  Anesthesiology       Date:  1974-02       Impact factor: 7.892

3.  Effect of a local anesthetic upon calcium uptake and insulin secretion by isolated islets of Langerhans.

Authors:  G R Brisson; F Camu; F Malaisse-Lagae; W J Malaisse
Journal:  Life Sci I       Date:  1971-04-15

4.  Effects of halothane anaesthesia and surgery on human growth hormone and insulin levels in plasma.

Authors:  T Oyama; T Takazawa
Journal:  Br J Anaesth       Date:  1971-06       Impact factor: 9.166

5.  Effect of cyclopropane anesthesia and surgery on carbohydrate and fat metabolism in man.

Authors:  T Oyama; T Takazawa
Journal:  Anesth Analg       Date:  1972 May-Jun       Impact factor: 5.108

6.  Carbohydrate metabolism and insulin release during ether and halothane anaesthesia.

Authors:  N Yoshimura; K Kodama; J Yoshitake
Journal:  Br J Anaesth       Date:  1971-11       Impact factor: 9.166

7.  Major inhalation anesthetics and carbohydrate metabolism.

Authors:  R G Merin; P N Samuelson; D S Schalch
Journal:  Anesth Analg       Date:  1971 Jul-Aug       Impact factor: 5.108

8.  Effects of spinal anaesthesia and surgery on carbohydrate and fat metabolism in man.

Authors:  T Oyama; A Matsuki
Journal:  Br J Anaesth       Date:  1970-08       Impact factor: 9.166

9.  Glucose tolerance during anaesthesia and surgery. Comparison of general and extradural anaesthesia.

Authors:  A Houghton; J B Hickey; S A Ross; J Dupre
Journal:  Br J Anaesth       Date:  1978-05       Impact factor: 9.166

10.  Effects of enflurane (Ethrane) anaesthesia and surgery on carbohydrate and fat metabolism in man.

Authors:  T Oyama; A Matsuki; M Kudo
Journal:  Anaesthesia       Date:  1972-04       Impact factor: 6.955

View more
  2 in total

1.  Bibliography for the control of anxiety, fear and pain in dentistry.

Authors:  G L McAlister; C L Richardson
Journal:  Anesth Prog       Date:  1982 Nov-Dec

2.  Decreased glucose utilization during prolonged anaesthesia and surgery.

Authors:  T Tsubo; T Kudo; A Matsuki; T Oyama
Journal:  Can J Anaesth       Date:  1990-09       Impact factor: 5.063

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.